William Blair Initiates Coverage of PacBio, Complete Genomics | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment house William Blair on Monday initiated coverage of Pacific Biosciences and Complete Genomics.

Analyst Amanda Murphy gave PacBio a "Market Perform" rating and an "Aggressive Growth" profile, and in a research note, said that the Menlo Park, Calif.-based firm is "on track to be the first company to successfully commercialize third-generation sequencing technology."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.